Rebecca M. Burke, Ph.D.
Affiliations: | 2012 | Pharmacology and Experimental Therapeutics | Boston University, Boston, MA, United States |
Area:
NeuroscienceGoogle:
"Rebecca Burke"Mean distance: 17.08 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentorSusan E. Leeman | grad student | 2012 | Boston University | |
(Bone morphogenetic protein 9 and insulin-like growth factor 2 modulate the cholinergic phenotype of the basal forebrain cholinergic system: Relevance to aging and Alzheimer's disease.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mellott TJ, Pender SM, Burke RM, et al. (2014) IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice. Plos One. 9: e94287 |
Burke RM, Norman TA, Haydar TF, et al. (2013) BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 19567-72 |